Rare diseases
Investigational molecules
Locations
A study of DS-3790A, rituximab, and epcoritamab in patients with blood cancers
FranceA study to evaluate the safety and effectiveness of nucresiran and vutrisiran in patients with hereditary transthyretin amyloidosis with polyneuropathy
CyprusA study of islatravir and ulonivirine for adults with HIV who have not received previous treatment
FranceA study to evaluate the safety and effectiveness of empasiprubart and efgartigimod alfa in patients with generalized myasthenia gravis.
BelgiumA study of IM-101 in adults with generalized myasthenia gravis or ocular myasthenia gravis
BulgariaA Study to Evaluate LY3537021 and a Drug Combination for Treating Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
FranceA study to evaluate the effects of lutetium (177lu) vipivotide tetraxetan in patients with metastatic hormone sensitive prostate cancer receiving androgen deprivation therapy.
GermanyA study of pembrolizumab, cetuximab, and MK-1084 for patients with advanced or metastatic non-small cell lung cancer with KRAS G12C mutations
FinlandStudy of the efficacy and safety of inclisiran and a drug combination in patients with acute coronary syndrome
FranceA study to evaluate the effectiveness of pirtobrutinib in elderly and frail patients with mantle cell lymphoma who have not yet received treatment.
ItalyA study to evaluate the effectiveness of AZD5148 in preventing the recurrence of Clostridioides difficile infection in adults.
DenmarkStudy of Revumenib, Cytarabine, and Fludarabine in Children with Relapsed or Refractory Acute Myeloid Leukemia
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.
